Lim Kenneth I, Delisle Marie-France, Austin Sandra J, Wilson R Douglas
Centre for Prenatal Diagnosis and Treatment, British Columbia Women's Hospital, and The Division, University of British Columbia, Vancouver, Canada.
Fetal Diagn Ther. 2004 Nov-Dec;19(6):491-5. doi: 10.1159/000080161.
To evaluate whether the cephalic index (CI) in trisomy 21 (T21) and trisomy 18 (T18) fetuses is different from that in euploid fetuses, and if so, is this difference of clinical utility.
Retrospective. Over an 18-month period, patients attending a single centre for routine advanced maternal age amniocentesis were recruited for a prospective study of ultrasound soft markers of aneuploidy. This prospective database was searched for cases with the following criteria: (1) occipitofrontal diameters (OFD) measured at least twice; (2) gestational age between 98 and 126 days either by ultrasound-confirmed menstrual dates or early second- trimester biometry; (3) no major central nervous system abnormalities detected on prenatal ultrasound, and (4) normal fetal karyotype. This constituted the control group. The study group consisted of all cases of prenatally diagnosed T18 and T21 identified in the same time period with criterion 2 as above. The fetuses in the study group had the OFD measured in a blinded fashion from the biparietal diameter images. CI (= mean biparietal diameter/mean OFD) was calculated for all fetuses. Pearson coefficient and regression analysis were used to determine independence of CI to gestational age in the control group. Standard descriptive statistics were used to describe interval data and two-tailed t test was used to compare means between the study and control groups. ROC curves were constructed to evaluate the clinical efficacy of CI for T18 and T21.
Five hundred and ninety-seven fetuses were available for analysis. There were 551 fetuses in the control group and 46 in the study group. Within the study group, there were 30 T21 and 16 T18 fetuses. Within the control group, CI was independent of gestational age (R = 0.026, p = 0.922). Mean CI for the control group was 0.802 (SD 0.040) and this was not statistical different from either the T21 group (mean 0.816, SD 0.042, p = 0.067) or the T18 group (mean 0.792, SD 0.057, p = 0.491). Area under the ROC curves was determined for both T18 and T21 and both had poor results (0.545 and 0.598, respectively). When CI was evaluated in the control group according to the two main ethnic groups in the study, there was a trend towards a statistical difference (p = 0.046) between the fetuses of Oriental and Caucasian mothers.
In this retrospective study, CI was not found to be statistically different between the study and control groups. Although a trend towards significance was seen with T21, this difference is not clinically useful. There may be interethnic differences in the CI between fetuses. CI is not useful for aneuploidy screening by ultrasound.
评估21三体(T21)和18三体(T18)胎儿的头指数(CI)是否与整倍体胎儿不同,若存在差异,这种差异是否具有临床应用价值。
回顾性研究。在18个月的时间里,招募到某单一中心因高龄产妇进行常规羊膜穿刺术的患者,对其进行非整倍体超声软指标的前瞻性研究。在这个前瞻性数据库中搜索符合以下标准的病例:(1)枕额径(OFD)至少测量两次;(2)通过超声确认的末次月经日期或孕中期早期生物测量法确定的孕周在98至126天之间;(3)产前超声未检测到主要中枢神经系统异常;(4)胎儿核型正常。这构成了对照组。研究组由同一时期产前诊断为T18和T21且符合上述标准2的所有病例组成。研究组的胎儿通过双顶径图像以盲法测量OFD。计算所有胎儿的CI(=平均双顶径/平均OFD)。使用Pearson系数和回归分析来确定对照组中CI与孕周的独立性。使用标准描述性统计来描述区间数据,并使用双尾t检验比较研究组和对照组之间的均值。构建ROC曲线以评估CI对T18和T21的临床疗效。
597例胎儿可供分析。对照组有551例胎儿,研究组有46例胎儿。在研究组中,有30例T21胎儿和16例T18胎儿。在对照组中,CI与孕周无关(R = 0.026,p = 0.922)。对照组的平均CI为0.802(标准差0.040),这与T21组(平均0.816,标准差0.042,p = 0.067)或T18组(平均0.792,标准差0.057,p = 0.491)均无统计学差异。确定了T18和T21的ROC曲线下面积,两者结果均较差(分别为0.545和0.598)。当根据研究中的两个主要种族群体在对照组中评估CI时,东方和白人母亲的胎儿之间存在统计学差异趋势(p = 0.046)。
在这项回顾性研究中,未发现研究组和对照组之间的CI有统计学差异。虽然T21组有显著差异趋势,但这种差异在临床上并无用处。胎儿之间的CI可能存在种族差异。CI对超声非整倍体筛查无用。